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Abstract: It has been well established that a vegetarian and polyphenol-rich diet, including fruits,
vegetables, teas, juices, wine, indigestible fiber and whole grains, provide health-promoting phytochemicals
and phytonutrients that are beneficial for the heart and brain. What is not well-characterized is the affect
these foods have when co-metabolized within our dynamic gut and its colonizing flora. The concept
of a heart shunt within the microbiota-gut-brain axis underscores the close association between brain
and heart health and the so-called “French paradox” offers clues for understanding neurodegenerative
and cerebrovascular diseases. Moreover, oxidation-redox reactions and redox properties of so-called
brain and heart-protective foods are underappreciated as to their enhanced or deleterious mechanisms
of action. Focusing on prodromal stages, and common mechanisms underlying heart, cerebrovascular
and neurodegenerative diseases, we may unmask and understanding the means to better treat these
related diseases.
Keywords: French paradox; polyphenol; cerebrovascular; heart brain shunt; microbiota-gut-brain
axis; Trimethyl-Amine-N-Oxide; TMANO; TMAO; co-metabolism; Alzheimer; vascular dementia;
redox; HMG-Co A; red wine; blood brain barrier; Celiac disease; leaky gut
1. Introduction
Part I, of a two-part series of concept papers, focuses on novel findings involving nutrition,
biochemistry, microbiology and metabolism to suggest a heart shunt, as occurs when two organ systems
are coupled and in this case within the microbiota-gut-brain axis. Here, we explore the bacterial species
that contribute to disease and to health and suggest oxidative and inflammatory mechanism drive
heart and brain disease and that wine polyphenols help protect us from bacterial-derived deleterious
metabolites. Exploring aspects of co-metabolism within the microbiota-gut-brain axis and metabolites
from prosaic foods could lead to a unifying hypothesis for age-related diseases and advance our
understanding of vascular dementia, neurodegeneration and heart disease.
Microorganisms 2020, 8, 490; doi:10.3390/microorganisms8040490 www.mdpi.com/journal/microorganisms
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When one considers ways to affect and modulate one’s own health, one must start with diet
and lifestyle. After this, we then turn to the host resident microbial ecology. Findings from host
digestion with gut microbiota and mycobiota co-metabolism suggest we can explore mechanisms
of disease and new treatment approaches to modulate health. To simplify our understanding of
the two most common and extremely complex diseases in the world today, namely coronary heart
disease (CHD) and Alzheimer disease (AD), we describe a shunt between the heart and the brain,
where commensal microorganisms though the microbiota-gut-brain (MGB) axis do affect both the heart
and the brain, which are coupled through the vasculature.
The gut microbiota has largely coevolved, in beneficial ways with their hosts, where they co-metabolize
dietary foods in symbiosis. The relationship provides both a niche for the microbes, and extracts vitamins,
vital nutrients and energy from diverse dietary sources for their hosts and themselves. In fact, it could
well be that some microbe-provided nutrients have negated the need for de novo synthesis by their hosts
and the symbiont’s production of some metabolites demonstrate antagonistic pleiotropy [1], which are
just vestigial remnants of an evolutionary past. The case could certainly be argued for some vitamins
and cofactors and bacteria may even have contributed to loss of functional genes for some of these
nutrients during evolution. Regardless, it is without question that animals, plants and bacteria coevolved
over time to survive, adapt and reproduce. It is this intrinsic co-metabolism that we feel hold the answers
to our unrelenting questions of how and why we are plagued with diseases in the first place and what can
be done to affect change in neurodegenerative pathobiology and its prevention.
We know the microbiota are involved in the early development of the blood-brain barrier [2].
In fact, homeostasis and establishment of the circulatory system and immune system are influenced by
gut bacteria and their metabolites [3]. Further, oxidative and inflammatory stressors are key propagators
of disease pathogenesis for the brain and the heart. Therefore, antioxidant foods and anti-inflammatory
agents are expected to provide the most impact on disease prevention and treatment and much of this
is expected to be derived from food. Conversely, a poor diet could do just the opposite, contributing to
disease by similar mechanisms.
2. The French Paradox
In search of beneficial dietary sources for health-promoting compounds led to fruits, vegetables,
wine and grape juice, as their consumption was inversely correlated with coronary heart disease (CHD).
Moreover, within populations who consumed a lot of red wine, it was observed that a paradox of sorts
existed within one population in particular because they consumed foods known to be deleterious
for heart health, yet had little heart disease. Thus, the cardio-protective effects of wine began to be
enthusiastically studied and has come to be known as the “French paradox [4]. This peculiarity largely
surrounds the observation that the French diet is rich in lipids and fatty foods but French people
have relatively low morbidity and mortality from cardiovascular and other heart-related disease.
How the French are able to consume very rich fatty and saturated lipid-rich foods in greater quantities
than most other groups, while remaining relatively unaffected in their cardiovascular health remains
a mystery and at the same time their Alzheimer disease risk is lower than some other populations
and certainly lower than those that consume a very high fat diet [5]. Nevertheless, we know that what
is good for the heart is also good for the brain, most likely involving the shared cerebrovascular system
and this is a more important consideration today, since, world-wide, one in three deaths is attributed
to cardiovascular disease [6].
As the popularity of the French paradox increased, so did the need for evidence-based research. It is
believed the French paradox is explained by the red wine constituents, which protect the French from
heart attacks and have other health benefit. These foods are rich dietary sources of a class of compounds
called flavonoids, which are small molecular weight polyphenols. To date, no less than 8000 phenolic
structures having been identified in plants [7]. Polyphenols are classified by the number of phenol rings
and the chemical substituents attached to these rings. Suggested mechanisms of action for polyphenol
constituents are related to their antioxidant capacity, anti-inflammatory activity and signal transduction
Microorganisms 2020, 8, 490 3 of 28
pathway activity [7]. Some of these compounds are reported to have low dose hormetic effects activating
stress response pathways when exposed to reactive oxygen species, free radicals, superoxide anion,
hydrogen peroxide, reactive nitrogen species, nitric oxide, peroxynitrite anion (ONOO) or hydroxyl
and peroxyl radicals [8]. Other sources of ROS include xanthine and flavin oxidases and cytochrome
P450, which subsequently activate ROS elimination systems and at the same time [9] Fenton reactions
can be produced during food digestion [9]. However, finding the hormetic zone within microbial
co-metabolism or with bacterial toxin exposure is likely far off from the scientific community’s radar.
Nevertheless, how the same foods impart health and play a part in disease is not a mutually exclusive
concept and our review will demonstrate that the gut microbiota and oxidative stress-mediated
inflammatory process is likely the deciding regulator within these apparently disparate findings.
3. Gut Redox Pairs and the French Paradox
The topic of wine is frequently mentioned in nightly news reports. Often broadcasters cite
the latest study to recommend the consumption of a glass of wine per day, or beer for that matter,
will benefit human brain and heart health. Nevertheless, studies often have many limitations, but even
fewer mention metabolism involving bacterial action or suggest redox properties of the constituents
or metabolites of those prosaic foods. Redox potential, as in redox-paired compound activity,
is an important environmental feature. The ability for redox pairs to find each other and have
any activity is readily affected by host and bacterial metabolism and the microenvironment where
the interaction occurs. When considering redox pairs for wine constituents, their potential when paired
with deleterious reactive species is an important but under-appreciated feature of the gut environment.
Both host and microbial enzymatic and non-enzymatic action, coupled with varying degrees and states
of oxygen tension, are but a part of the dynamic involved in understanding protective mechanisms
for polyphenols. Importantly, dietary polyphenols that are not taken up by bacteria for metabolism,
pass through the small to the large intestine the gut lumen and are taken up by enterocytes or other
intestinal cells enter the gut lumen and are subject to host and liver metabolism and modification,
such as phase 1 and 2 conjugation.
These phenolic compounds certainly become oxidized themselves to quinones and protect from
oxidation-mediated damage but, quinones are potentially oxidizing as well. It would be a paucity
of antioxidants or other mechanisms that would either contribute to or protect against disease
pathogenesis. Few have considered whether microbial-host metabolism, or redox properties of
bacterial-derived molecules, would interact with prosaic foods to either antagonize or synergize in
disease pathogenesis. We suggest some of the action occurs either by directly possessing enzymatic or
regulatory substrate interaction or by forming complexes, such as chelating redox metal-bound moieties,
acting as glycation intermediates or via other oxidation-quenching mechanisms. Since polyphenols
are powerful antioxidants and scavengers of ROS and RNS they protect extracellular lipids, proteins
and nucleic acids from redox damage but questions remain as to whether some antioxidants or
phytochemicals potentially could do more harm than good, as increases in glycation-mediated
protein damage have been reported [8]. Far less is known about whether or how phenolic acids
and phytochemicals pass barriers to act intracellularly or in brain compartments. In aerobic cellular
systems, the redox potential and redox pairing metabolites are largely governed by extracellular
reactive oxygen and nitrogen species, whereas in anaerobic systems, the bacterial species and supply of
their reducing metabolites reflect the net antimicrobial potential of gut contents [10]. Generally, carbon
dioxide, sulphur dioxide, zinc oxide and oxygen elevate redox potential and hydrogen depresses it.
Therefore, it is wise to consider these redox pairs and interactions with foods and their metabolites
when thinking of mechanisms of action. We suggest further study and the development of next
generation mass-spectral approaches and metabolic interactome methodologies be devised.
Since we cannot escape oxidative metabolism and oxidation is a common biochemical enzymatic
mechanism, we must consider oxidation-reductions in vivo. Oxidation reduction or redox potential
(Eh) is measured in millivolts and represents the affinity of electron transfer to or from a chemical
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species in solution. The ability to either gain or lose electrons in that particular environment is
concentration and temperature dependent. Chemical species with higher, more positive, reduction
potentials than a particular species introduced into the system trend to gain electrons from the new
species, become themselves reduced by the oxidizing species and solutions with lower, more negative,
reduction potential tend to lose electrons to the new species and become themselves oxidized by
reducing the new species [11].
Within the gut, intestinal segments, the crypts lining it and other environmental niches within
the gut continuum have changing redox states and differences in oxygen tension and the resident
bacteria play a large role in maintain redox potential within these environmental segments. Moreover,
it has been shown that imbalances between pro-oxidative and anti-oxidative mechanisms play a key role
in the pathogenesis of irritable bowel disease and related intestinal damage [12,13]. For instance, strict
aerobic bacteria are largely active at positive redox values, whereas strict anaerobes are generally active
at negative Eh values and facultative anaerobes can be active at both positive at negative Eh values and in
the presence of oxygen bearing nitrogenous or sulfurous inorganic compounds. In cellular metabolism
oxygen, nitrate, chlorite, nitrite, iron, copper, sulfate, hydrogen peroxide, manganese and CO2
serve as inorganic oxidants, while reduced inorganic compounds, metals and organic substrates like
hydrogen sulfide (H2S) serves as reductants [12] Probiotic bacteria do scavenge ROS and degrade Fenton
and Haber-Weiss reaction products such as superoxide anion and hydrogen peroxide, which are not
restricted to their metal chelating ability and significantly attenuate exopolysaccharide (EPS)-produced
oxidative damage in a rat model of colitis [14].
Other central nervous system (CNS) antioxidants include diffusible bioactive gasses like molecular
hydrogen (H2) as dihydrogen and H2S, which have having antioxidant activity, such as reducing
hydroxyl radicals and peroxynitrite from microbiota potentially generate up to 1 L per day during some
fermentation processes [15]. Small amounts of H2S are produced by host metabolism, but it is mostly
by hydrogen-producing bacteria, which include anaerobic cocci, certain strains of Clostridium and some
Enterobacteriaceae, among others. H2S can inhibit Complex IV within the mitochondrial electron
transport chain [16,17]. Production of H2S is usually accompanied by symbiotic co-metabolizing
species that consume H2S as in the case of sulfur and sulfate-reducing bacteria, methanogens,
and acetogens bacteria [18]. The production of H2 has intra- and inter-individual variability in relation
to microbial composition and dietary choice. Since H2 is by far gut bacteria-derived and not of
human origin [16] it is plausible that gut dysbiosis results in decreased protective H2 production for
the CNS, vulnerable neurons and increases oxidative stress susceptibility in all ROS-related disorders.
This is supported by Parkinson disease findings [19]. Some oxidizing enzymes, such as dioxygenase,
polyphenol oxidase (PPO) and quercetinase, mediate catabolic conversion of select polyphenols in
the anaerobic colon. Since the colon is an anoxic environment, as compared to the small intestine, these
enzymes depend on molecular oxygen for their catalytic activity yet activity occurs here. Perhaps there
is some slightly higher oxygen tension in the gut wall or crypts. Nevertheless, stochastic and oxidative
mechanism occur under conditions of very low oxygen tension in the gut [20].
Redox potential is an important environmental feature, affected by both host and microbial
actions, and redox reactions are important for determining carbon and nutrient cycling in bacterial
and other systems [21]. In solution, redox conditions affect the nutrient and free metal ion solubility
and availability. For instance, gut bacteria are known to interfere with the intracellular NADH/NAD+
ratio in their competitors, such as Clostridium acetobutylicum [22]. They accomplish this by using
different substrates reducing capacity, e.g., pyruvate, glucose and glycerol [23]. Because molecular
oxygen, involved in keeping metabolism in flux, synthesizing unsaturated fatty acids/sterols and for
maintaining cell membrane integrity and function, regulating the levels of dissolved oxygen in solution
is important for host and bacterial metabolism. This holds for microorganisms that propagate under
optimum physiological redox conditions in the gut. Moreover, antibiotics change host and microbial
functioning and can perturb gut redox potential, which increased within hours after dosing in mice [10]
and this group found shifts in redox potentials were specifically attributable to bacterial suppression
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and blooms of the bacterial family Enterobacteriaceae species in a host-free human gut model of
the microbiota.
Molecular oxygen (O2) is considered to be a driver of gut dysbiosis [24] and we know gut microbes
contribute to redox signaling [25]. The gut microbiota oxidation-reduction potential, e.g., capacity for
the microbiota to gain electrons, also influences the homeostasis of the intestinal-blood barrier [10],
while at the level of the brain and CNS, modulates intestinal ROS levels via the vagal, cholinergic
and anti-inflammatory pathways [26,27]. Further, oxidative and inflammatory stress can lead to distal
breaches for other immune privileged barriers in humans [3].
Since there is a direct link between fecal redox potential, human digestive microbiome and its
health, Million and co-workers explored links between anaerobic depletion, increased redox potential
in various systems and during severe acute malnutrition [28]. They found intestinal redox-related
indicators were significantly correlated with the distribution of gut microbiota and diet is a key
consideration. Interestingly, processed meats are considered non-healthy because many contain
heme-iron, an oxidant and source of redox active metal, and high fat, salt and nitrite content.
In particular, red meat with abundant nitrates form free radicals in the human gut. Researchers tested
various natural compounds, such as tea polyphenols and Polygonum cuspidatum and rosemary extract
to counteract the effects oxidation in the gut and experiments were carried out to add polyphenolic
compounds into meat processing to improve upon its relative unhealthiness [29]. This group found
the addition of polyphenols and extracts reduced the oxidation-reduction potential of meat products
and increased their antioxidant status.
Moreover, red wine, red grape juice and prune juice also affects gut oxidative stress as they are
known to have profound inhibitory effects on iron bioavailability [30]. These inhibitory effects are
likely due to high levels of particular polyphenols that bind redox-active iron species and prevent
its absorption. Many things feed bacterial growth and during sepsis or anthrax exposure, free iron
feed bacterial growth and these processes are life threatening. Our acute phase reactive proteins,
like C-reactive protein and those that bind ferritin and other iron binding proteins are upregulated to
sequester microbial growth-enhancing elements like iron [31]. This is clearly an evolutionary defensive
approach in managing infections and sepsis in animals. Together, these findings show a potential to
manipulate the gut microbiota through managing bacterial respiration and polyphenol administration.
4. Possible Mechanisms for the French Paradox
When considering potential mechanisms for the French paradox, it is important to note that
wine is a natural statin. The effects of red wine and both of the aforementioned statins are directly
traced back to their ability to inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase. We call
this so-called HMG-Co A reductase inhibitor action. HMG-Co A is an NADPH-dependent enzyme
and the rate-limiting step of the metabolic pathway that produces cholesterol and other isoprenoids,
namely, the mevalonate pathway. HMG-Co A reductase reduces cholesterol and biosynthesis of
ubiquinone and other molecules in this lipid synthesis pathway like isoprenoid production as well
as the production of many other biomolecules. Isoprenoids activate a Rho family member of G-proteins
involved in inflammation and these compounds then lower inflammation. The author has shown
a clear connection between G-protein receptor kinase 2 (GRK2) and AD [32], which was the basis for
the concept of the heart-brain connection in vascular AD, vascular dementia (VaD) and other forms of
Alzheimer disease [33].
The French paradox and polyphenol involvement could be further explained specifically by vitisin
A and vitisin B, which have strong inhibitory activity against HMG-Co A reductase [34]. Moreover,
Vitis vinifera has inhibitory effects on HMG-Co A reductase through metabolites of the mevalonate
pathway [8], which are unique from its statin-like activity and those affecting cholesterol levels,
vascular tone hemodynamics or potential control of vascular function [35]. When Roullet and colleagues
explored Lovastatin in rat heart explant tissue, they found the opposite effect in vivo and in vitro
as Lovastatin increased blood pressure, enhanced vascular response to norepinephrine, and impaired
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endothelium-dependent and independent relaxations. On a whole, they found mevalonic acid
metabolites decrease blood pressure in the whole animal without significant change in plasma
cholesterol [35]. Thus, pharmacological inhibition of mevalonate production as a means to lower
plasma cholesterol may have an adverse impact on cardiovascular risk factors, such as blood pressure.
Moreover, the use of polyphenols and wine to block cholesterol production should be weighed carefully
in terms of cost benefit.
Alcohol maybe protective for CHD by increasing serum high density lipoprotein, decreasing
cholesterol levels and by inhibiting platelet reactivity [36]. Aside from alcohol in the wine, we described
many wine constituents that may explain the French paradox [37], such as polyphenols, which do explain
some of the health disparity of the so-called paradox as they have particular importance to diabetes,
cancer, aging and neurodegenerative diseases. This may be due, in part, through multifactorial effects on
post-translational modifying enzymes that affect histone protein acetylation patterns for example [38].
However, these same health-promoting compounds are attributed to the so-called Mediterranean diet
as well, which is one generally rich in vitamins, high-fiber, fruit and vegetables [39,40].
Many fruits and juices contain phenolic acids, polyphenols and indigestible carbohydrates, such as
pectin, hemicellulose and various polysaccharides. It is this aspect of the diet that both supports
select gut microbiota species and colonization through co-metabolism, whereby the gut microbiota
can impart many beneficial effects on health through sustained co-metabolism of health-promoting
foods. The microbial fermentation by-products are short chain fatty acids (SCFAs), particularly acetate,
propionate, and butyrate [41]. These prebiotics, in fact, may act synergistically to modify colonic
and intestinal microbiota, which form a symbiosis and benefit human health [42]. In that regard,
we found protective aspects of butyrate from the prebiotic potato starch with Faecalibacterium prausnitzii
on Clostridium difficile infection and damage [43]. Others found prebiotic effects, using 16S rRNA
pyrosequencing of the microbial DNA prepared from stool co-incubated with select fruits when
fermented with feces from 10 donors [42]. This group found an immediate and long-lasting reduction
in the abundance of all members of the Proteobacteria phyla as well as some members of the Firmicutes
phyla and Bacteroidetes phyla, which were originally present in the original fecal inoculum. Further,
the abundance of Ruminococcaceae or Firmicutes decreased in 24 h by half. In contrast, Bacteroidaceae,
Lachnospiraceae and Veillonella members of the Firmicutes phyla and Coriobacteriaceae of the Actinobacteria
phyla increased over 24 h. The Lachnospiraceae levels were sustained for up to 48 h and Coriobacteriaceae
and Bifidobacteraceae Actinobacteria increased [42]. Further, they showed that Proteobacteria, Actinobacteria,
Firmicutes and Bacteroidetes all compete for dietary carbohydrate in a closed system. Proteobacteria have
a preference for host carbohydrates and mucin-derived and secondary metabolites.
When fermented kiwifruit was added, SCFAs increase, while lactate and after 24 h succinate
concentrations declined and most of the genera observed produced acetic acid [42]. Propionic
acid is a SCFA product of Bacteroidetes fermentation and from Veillonella, members of the phyla
Firmicutes. Butyrate, produced mainly by the Firmicutes subset, among others, features members of
the Lachnospiraceae family [42]. Additionally, in the aforementioned study by Juliet and colleagues,
by-products of fermentation contributed to the first step in microbial colonization by modulating both
microbial numbers and gut flora ecology through adhesion of different bacteria to the gut wall [44].
In the gut, this offers stable colonization and these adhesion effects are consistent with the work on
pectin, whereby fractions rich in galactose, arabinose, and galacturonic acid enhanced the adhesion of
Lactobacillus rhamnosus to Caco-2 cells in vitro, but inhibited the adhesion of Salmonella enterica [45]
The differential adhesion of pathogens vs. commensal establishment is another example of how our
niche microbiota in well matched to us and contribute to our health.
5. Redox Active Polyphenols and Phenolic Acids
Oxidants are chemical species able to remove electrons from electronegative atoms or other
molecule’s electrons and then accept those electrons the scavenged species then become oxidized [46].
But there is a double-edged sword to many redox active compounds in the gut and some may even
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to contribute to heart disease through the redox action of select microbiota. In red wine, the main
polyphenolic constituents are a class of phytochemicals called flavonoids or flavones and flavanols,
anthocyanidins [47], which includes their oxidation products [48] (See Figure 1). These small molecular
weight flavonoid class of compounds provide antioxidant activity based on redox potential. They serve
as electron donors to select free radical derived oxidants, such as hydroxyl radicals and peroxyl
radicals due to favorable reduction potentials of peroxyl radicals [49]. Jovanovic and colleagues used
a model in aqueous solutions with azide radical induced single electron oxidation to generate phenoxyl
and flavonoid radicals and investigate their acid–base and redox properties. This may also help protect
the French from lipid peroxidation and heart disease [50]. Moreover, xenobiotic molecules could affect
the CNS and brain at both the blood-brain-barrier interface [51] and from gut dysbiosis, which could be
a cause and a consequence of increased levels of oxidative stress since anaerobes thrive in the presence
of electron acceptors [52].
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A reaction that is well-quenched by many polyphenols is the Fenton reaction, which involves
hydroxyl radicals. This and other oxidative mechanisms affect redox signaling, activate survival
pathways mediated by “redox sensors” and modulate the expression of certain anti-oxidant enzymes,
which are kept under control by soluble and insoluble redox sinks, i.e., compounds able to quench
oxidative stress or free radical species. The endothelium-derived Nitric oxide (NO), is a relaxing
factor and free radical and a neurotransmitter of the non-adrenergic non-cholinergic enteric nervous
system is the of the autonomous nervous system [53]. The systems modulate the level of oxidative
stress within the intestine via the vagal cholinergic anti-inflammatory pathway [54]. Importantly,
the central and enteric nervous systems interact with MGB axis via gut microbiota to regulate
neurotransmitter and hormone metabolism and the vagus nerve is a key node. The resulting
communication signaling contributes bidirectional control of gastrointestinal tract functions and related
brain behavior. In the opposing direction, communication affects afferent vagal nerves, which express
many receptors for gut peptides such as ghrelin serotonin and leptin to name a few. The enteroendocrine
cells that secrete peptides and small molecules are regulated to some degree by the microbiota
and the MGB axis.
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An important, but less concentrated constituent of red wine, is the phytoalexin resveratrol,
which is a naturally occurring phenolic acid and effective lipid-soluble antioxidant. In the recent past,
interest in resveratrol grew due not to its antioxidant properties but due to is activity as a histone
deacetylase, which was expected to be a new AD therapy [55]. Although it is not the most abundant
polyphenol in wine, trans-resveratrol has been reported to prevent Angiotensin II-induced hypertension
and endothelial dysfunction. It has also been shown to prevention of vascular nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase induction [56]. Moreover, Vigili and co-workers were
the first to demonstrate neuroprotection in rodents with trans-resveratrol form kainic acid injections in
the hippocampus and olfactory cortex [57].
However, we suggest alternative mechanisms may be favored and understanding examples
from plants and fruits may provide insight. Since flavonoids are ubiquitously synthesized in all
photosynthetic plants as an acute response phase compound under various stressors and during
environmental attack. Similarly, these same compounds, when ingested, are likely to protect against
the same environmental assaults and stressors common in human disease pathogenesis. One mechanism
helpful to plants and humans likely involves the ability for flavonoids to sequester and chelate
redox-active metals in response to heavy metal stressors [58]. Moreover, they are also produced
during ionizing radiation and during microorganism infection, where they have clear activity against
pathogens like bacteria, fungi and viruses [59]. However, the overall bioavailability of flavonoids,
when taken orally, may be lower than preferred.
Other putative factors in red wine that may be important to prevention cardiovascular disease
and risk are folic acid and nitric oxide, which some suggest are involved in the French paradox [60].
In bovine aortic endothelial cells, vascular homeostatic changes occur when ET-1 is over-expressed
and leads to changes in distribution and in tyrosine phosphorylation [61] which may implicate
red wine components in multiple signal transduction pathway action or inhibition. In that regard,
cellular targets of flavonoids are likely kinases involved in signal transduction pathways like MEK,
Raf and PI3K [61]. Recently, interest in microbial metabolism of polyphenols, phenolic acids and similar
red wine components has grown and is a promising area of research for medicinal chemistry [62].
Important in the red wine debate is its ethanol content as alcohol participates in free radical
reactions within biological systems though production of alkoxy-free and hydroxyl-free-radicals
as the initial reaction products [63]. However, ethanol may enhance cellular oxidative stress and be
deleterious under some conditions by producing superoxide anion and hydrogen peroxide. Conversely,
moderate ethanol consumption is considered beneficial, because it is known to decrease inflammation
and inflammatory markers in adipocyte tissue explants and attenuated whole-body inflammation
and lowered soluble tumor necrosis factor receptors in vivo [64] and does lower other inflammatory
mediators, such as soluble tumor necrosis factor (TNF) receptors l and ll and other cytokines [65].
However, polyphenols are not the only protective compounds in a vegetable-rich diet. Multiple
antioxidant properties of flavonoids have been noted each with different mechanisms of action.
In particular, they trap reactive oxygen species and inhibit enzymes involved in the production of
oxidative stress. Flavonoids also block radical formation that occur through Fenton type reactions
and even regenerate other antioxidants, such as α and γ-tocopherols (vitamin E). Radical trapping
experiments by Drouza and colleagues, demonstrated that the vanadium complexes in edible oil
activate the one electron reduction of dioxygen to super-peroxide radical anion that reacts with lipids
to form lipid hydroperoxides and react with the phenols contained in the oils [66]. ROS-trapping
mechanisms, through the oxidation of flavonoids to short-lived radicals, regenerates vitamin E.
These radicals usually decay quickly into non-radical oxidation-degradation products via complex
pathways and vitamins E and C both are labile, acting as antioxidant as well as pro-oxidants.
6. Lipid Metabolism, Oxidation and the French Paradox
Human plasma contains many sulphur-containing proteins with intrinsic antioxidant properties,
including glutathione peroxidase, thiols, some in their active site, as well as transition metal binding
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proteins, albumin and many oxidases and reductases that protect endogenous lipids proteins and nucleic
acids from damage [67]. Inhibitors of lipid peroxidation and oxidation damage to low-density
lipoprotein (LDL) are useful phyto-protective compounds and polyphenols, particularly the catechins,
are effective chain-reaction breaking antioxidants and scavengers of free radicals and polyphenols
do this as well. The mechanism is to spare LDLs, which are rich in polyunsaturated fatty acids
(PUFA)s and are a major cholesterol carrying lipoprotein in plasma. Elevated levels of LDL, PUFAs
and cholesterol directly contribute to atherosclerotic disease and lipid oxidation is strongly implicated
in this process. The oxidation process promotes the accumulation of cholesterol-esters on arterial
walls and in endothelial cells, which is the first step in the LDL oxidation cascade which includes
the oxidation and degradation to aldehydes of polyunsaturated fatty acids. Here, monocytes catalyze
the process becoming resident macrophages where they directly contribute to bystander generation of
reactive oxygen species damaging the vascular microenvironment as they attempt to remove the plaque
deposits through immune clearance mechanisms. The activation of several phox-regulatory complex
of enzymes, and oxidative bursts from macrophages, feed this cascade forward. When macrophages
ingest oxidized deposits, such as oxidized LDL and oxidized apolipoprotein small a, they transform
into so-called foam cells, which we see as fatty steaks in affected atherosclerotic vessels and polyphenols
likely could prevent this cascade in the first place [67].
Lipid peroxidation and oxidative stress with platelet aggregation and LDL oxidation, has been
inhibited by lipid soluble antioxidants, such as resveratrol and wine [67]. Further, inhibition of LDL
oxidation by flavonoids is suggested by the localization of catechins near the membrane surface and by
scavenging of aqueous radicals since they are ideally located in the aqueous phase interface where
they prevent the oxidation of the tocopherols leaving tocopherols to function in cells as a lipid peroxyl
radical scavenger [68]. Resveratrol is capable of scavenging lipid hydroperoxyl free radicals, hydroxyl
and superoxide anion radicals [69]. Others show in vitro that amelioration of oxidative damage
induced by hydrobutoxide was greater with resveratrol than with common redox-labile antioxidants
vitamin C and vitamin E [70]. Many enzymatic and non-enzymatic antioxidant defenses protect
circulating LDL and lipoproteins from oxidation, which is enhanced and catalyzed by circulating
free transition metals through Fenton and Haber-Weiss reactions as metallic ions remain redox active
even when protein bound [71]. Oxidized LDL can be reduced by antioxidants with minimal lipid
peroxidation. Inhibitory properties of polyphenols toward LDL oxidation via Fenton chemistry can
be calculated by several oxidation-potential indices and followed biochemically. In Fenton reactions,
this is divided into three phases; lag, propagation and decomposition, taking into account the initial
number of conjugated dienes, lag time, maximal rate of oxidation, maximal number of dienes formed,
and so on [8].
7. Alcohol and Red Wine Polyphenols Affect the Microbiota
The French have perhaps the highest intake of total alcohol and wine for any developed country [39].
Polyphenols are a particularly interesting general class of plant compounds that contain multiple phenol
groups in their chemical structure. Certain antioxidant characteristics found in red wine were attributed
to key phytochemicals that offer beneficial effects for modulating human health. Two main types
of polyphenols are known, namely regular flavanols and anthocyanidins. Stilbenes, like resveratrol,
are known but they have properties other than as antioxidants. When we study gut microorganisms,
often through DNA sequencing to reveal which species are present in a particular animal or system,
we also explore how the microbiota, mycobiota and other microorganisms respond individually or
collectively to a particular environment or milieu as they co-metabolize nutrients with their hosts.
We combine these approaches with analytical methods to focus on the small molecules produced
as microbes metabolize food and host metabolic products. Beyond genomics and computational
biology, we also use mass spectroscopy and bioinformatics to explore biochemically and physiologically
the production and movement of these molecules to the brain or other host compartments. These small
molecules are biomarkers of metabolism, where they could serve to chart health, disease, treatment
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efficacy or the progression of syndromes or sequelae related to co-metabolism between a host and its
resident microorganisms. We call this aspect of analytical science metabolomics or the systems biology
of metabolism [62].
Several classes of polyphenols are abundant in many foods, including tea, coffee, fruit, vegetables
and chocolate [72,73]. Those opposed to alcohol likely question why adding polyphenols to our diet
in the form of red wine, versus taking non-alcoholic sources or purified phenolic compounds in pill
form, would be at all beneficial or different. One important finding came after the work of Guarente
and Sinclaire, who isolated resveratrol and packaged it as a drug and fountain of youth dietary
supplement. Resveratrol’s drug application presents challenges for the pharmaceutical industry due to
its poor bioavailability, poor solubility and adverse effects. In that regard, dietary resveratrol in food is
present in more stable and bioavailable glycosylated forms, which prevent its enzymatic oxidation
in the gut. Furthermore, intestinal cells only absorb the resveratrol aglycone, which makes it more
effective as a whole food, at this time, rather than as an isolated compound [74].
More importantly, it was the Le Roy study that revealed grapes compared to other foods have
a much richer concentration of polyphenols in their skin, specifically in red grapes versus white
grapes and red wine had a higher polyphenol content compared to non-alcoholic grape juice [75].
Results of wine’s effect on the microbiota show that red wine consumption significantly increases
the concentration of Firmicutes, Bacteroidetes, and Proteobacteria phyla but not in those from the gin
or alcohol-depleted red wine group [76].This finding demonstrated the significance that small ethanol
doses with polyphenol intake is likely needed to create some of the observed changes in the gut
microbiota [76].
When considering the predominant red wine polyphenols studied, including the flavan-3-ol
monomers and proanthocyanidins, we often find associated antimicrobial activity, which may be
another reason why wine may be protective against heart disease as they affect the microbiota
by exerting inhibitory effects through binding to certain bacterial membranes [77,78]. As some of
these compounds reach high levels in the blood periphery and select organs, biologically significant
concentrations do affect the host and the microbiota. It is important to note that wine and tea contain
larger molecular weight tannins, phenolic concatemers and polymeric polyphenols. Condensed
and hydrolysable tannins, the proanthocyanidins, are known to impair nutrition, bind proteins
with soluble or precipitated complexes and affect intestinal absorption of foods including lipids [79].
The non-absorbable polyphenols, non-hydrolysable and hydrolysable tannins and dietary polyphenols
have provoked new ideas as to their physiological function, interaction with lipids and metabolism
involving the microbiota-gut [80]. We know a high fat diet induces metabolic disorders, but it also
induces gut microbial dysbiosis in mice, however, some polyphenols from tea possess the ability to
regulate dyslipidemia and gut microbiota dysbiosis [81].
Polyphenols, such as those in tea, the theaflavins, are considered to have antimicrobial
activity and underlie intestinal mechanisms that significantly ameliorated hyperlipidemia, improved
the expression levels of hepatic lipid metabolism genes and modulate the gut microbiota in mice [81].
The exact mechanisms for ameliorating hyperlipidemia are largely unknown, but potential health
benefits surrounding natural compounds are very much dependent upon absorption and disposition to
target tissues and cells. Thus, we suggest a caloric restriction mimetic effect, of tannins and resveratrol,
might be based simply on their ability to limit intestinal absorption of food [82]. One other underlying
mechanism rely on tea polyphenol maintenance of the intestinal redox state. Biomarkers for intestinal
redox state include an unidentified genus of Lachnospiraceae, Bacteroides, Alistipes, and Faecalibaculum
and suggest novel insights into the mechanism of tea polyphenols on intestinal redox homeostasis [83].
Studies show that regular moderate red wine consumption significantly modulates the growth
of select gut microbiota in humans by inhibiting non beneficial bacteria from the human microbiota
and potentiating the growth of probiotic bacteria. In a randomized, crossover and controlled
intervention study, researchers evaluated the effect of moderate intake of red wine polyphenols
on groups of human gut microbes [76]. Results of this study revealed that after daily red wine
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polyphenol consumption over 4 weeks, there was a significant increase in the number of Blautia,
Coccoides-Eubacterium rectale, Bifidobacterium, Eggerthella lenta, Bacteroides uniformis, Enterococcus,
Bacteroides, and Prevotella groups and importantly a decrease in the Clostridium genera. These include
Clostridium histolyticum, which produces collagenase that degrades animal tissue; Clostridium difficile,
which causes severe diarrhea and death; Clostridium perfreingens, which causes gas gangrene; and other
species responsible for disease in humans [76]. Clostridium perfringens is closely related with progression
of colonic cancer and the onset of inflammatory bowel disease [83], which is decreased after red wine
consumption. Eggerthella lenta and Bacteroides uniformis is associated with antiproliferative effects on
human prostate cancer cells and proliferation was decreased after red wine consumption [84]. Blautia,
Coccides-Eubacterium rectale species was found important for the prevention of colon cancer [85] or
ulcerative colitis [86] due to the presence of butyrate [87], which increased after red wine consumption.
In relation to bacterial composition, resveratrol another red wine component that was shown to have
beneficial effects on metabolic syndrome-related alterations in composition of bacterial species. Further,
this wine compound is generally associated with beneficial metabolic outcomes [88] and improvements
in gut microbial composition generally [75]. Results from twin studies revealed that the twin that
consumed more red wine had a healthier gut microbial pattern and a lower risk of obesity and bad
cholesterol compared to their twin counterpart who consumed less red wine. Another study exploring
the effects of red wine in the microbiota gut of nearly 3,000 people comprising of three different
countries namely, United Kingdom, USA, Belgium, showed that the high levels of polyphenols in
the grape skin of wine is associated with a healthy gut microbial pattern and grape skin polyphenols
could be responsible for many of health benefit associated with wine consumption [75].
Diffusible polyphenols are oxidized by PPOs to quinonic compounds. Quinones and amino
acids are usually compartmentally separated in vivo as they associate reversibly and irreversibly with
proteins and amino acids [89]. One junction where oxidized polyphenols meet, react and propagate their
influence is in the digestive tract. Here, quinone–alpha amino acid conjugates form with nucleophiles,
such as sulfhydryls, amines, amides, indoles and imidazole substituents to form imines and 1,4-Michael
additions through glycation mechanisms, which if not reversed form stable adducts and aldehydes
through Strecker degradation. These intermediates have germicidal activity, act as a cancer initiator
and are cytotoxic or have free-radical scavenging activity [8,89]. It is intriguing to consider role for
gut bacteria in redox regulation of a reversible polyphenol-quinone dynamic protecting sensitive
functional groups from glycation or oxidative stress mediated damage. However, this mechanism
is not well-characterized, but may add to the possibilities for wine to protect or prevent deleterious
damage in the gut and elsewhere.
8. Wine, Mediterranean Diet and Betaine
Wine contains many anti-inflammatory molecules, such as betaine, phenolic acids, alcohol and all
of which are able to lower inflammation. Folate contributes to the French paradox, since folate affects
homocysteine levels and a cardio-protective role is suggested [60]. Betaine may offer another mechanism
for the French paradox since it can participate in homocysteine methylation as a methyl donor and is
an alternative pathway in homocysteine detoxification. Since mutations and polymorphisms in
the methylene-tetra-hydro-folate reductase (MTHFR) gene and MTHFR pathway, affect its ability
to process folate, leading to heart disease by increasing levels of homocysteine. However, betaine
also originates from choline, which is a quaternary ammonium compound that can be oxidized
irreversibly to form betaine when catalyzed stepwise by choline dehydrogenase and betaine aldehyde
dehydrogenase in the liver and kidney [90]. Betaine, also known as trimethylglycine, is zwitterionic
compound, which could be a potential intermediate in Wittig reactionsbyrn, especially through
the Schlosser modification [91].
Betaine (See Figure 2) is another important osmolyte to stabilize tissue and cellular osmolarity,
protecting against osmotic stressors like high salinity or temperature. Intracellularly, betaine aids
in water retention and protects from dehydration. More importantly betaine serves as a methyl
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group donor in many methylation reactions and detoxification of homocysteine, a proatherosclerotic
metabolite. Hyperhomocysteinemia predispose affected individuals to endothelial cell injury,
to vascular inflammation and eventually to atherosclerosis. Atherosclerosis and coronary artery
disease manifest when an atherosclerotic plaque blocks blood flow to coronary or other arteries.
Betaine-homocysteine S-methyltransferase (BHMT) re-methylates homocysteine to methionine
producing dimethylglycine [92]. This reaction is an alternative to vitamin B12-folate-dependent
pathway for homocysteine detoxification [93].
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folate, vitamin B12, pantothenic acid, and biotin and choline [90]. These vitamins are grouped into
two categories: namely, those involved in the reactions of intermediary metabolism related to energy
production and redox status and those involved in the transfer of single-carbon units. Choline and the B
vitamins are essential for human health [100].
Choline helps maintain normal brain development and is derived largely from dietary
phosphatidylcholine consumption. Foods high in choline include fish, eggs and peanuts. Choline,
which occur in water soluble and lipid soluble forms, and the water-soluble B vitamins help maintain
proper system function and energy metabolism. Choline, as well as betaine, a choline metabolite,
play important roles in reducing inflammation and for our brain and cardiovascular health. Interestingly,
both of these compounds reduce plasma homocysteine levels, which a modified amino acid mainly
derived from meat consumption. High levels of homocysteine are linked to increased heart disease.
The author has shown a relationship between thiamin(e) and Autistic Spectrum Disorder (ASD) [101].
Moreover, the B vitamins thiamin(e), niacin, vitamin B6, riboflavin and pantothenic acid are
required for transamination, decarboxylation, acylation, oxidation, and reduction of numerous
substrates that eventually are involved in energy utilization and homeostasis. One or more of
the B vitamins are important for cholesterol, steroid, amino acid, fatty acid and glucose synthesis.
Several carboxylases require biotin for carbon dioxide fixation for respiration and the transmission of
the energy pathway requires methylation and vitamin D, 5-MTHF (active folate), methylcobalamin
(active vitamin B12), pyridoxal 5’-phosphate (active vitamin B6), betaine, choline, riboflavin
5’-phosphate (active vitamin B2) and magnesium are all needed for methyl-group transfer.
Their metabolism intermingles at the pathway for conversion of homocysteine to methionine.
Thiamine and pyridoxal sulfate are necessary for deoxyribonucleic acid (DNA) synthesis as is folate,
which supplies single-carbon units in the pathway. There is growing evidence that some B vitamins,
and choline may prevent the occurrence of developmental abnormalities and chronic degenerative
or neoplastic diseases [102]. However, others suggest they may contribute to neoplastic diseases,
exacerbate them or have no effect [103].
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eggs, organ and other animal foods, and carnitine is metabolized in the large intestine by gut
microbiota to trimethylamine (TMA) and to dimethylamine and methylamine albeit in lesser
amounts [106]. After absorption, host enzymes convert TMA to TMANO in the liver by liver
flavin monooxygenases [107]. TMANO formation in humans is poorly understood but it is purported
to enter the same metabolic pathway as its precursors, which is one of several proposed that may
contribute to bacterial pathobiology of clot-formation. We have quantified TMANO levels in many
rodent tissues, fluids and brain as well as in human CSF, but the origin of TMANO in the brain is not
well characterized [62] but it does illustrate an aspect of the Microbiota-Gut-Brain Axis Heart-Shunt,
that microbe-derived metabolites reach the brain and compartments but also have an effect on the heart.
The major precursor for TMANO in the human diet is choline, which increases urinary excretion
of trimethylamine and its N-oxide [108]. Following oral intake of choline, Zhang and colleagues
reported 63% of the dose as TMA and its N-oxide for D,L-carnitine (31% dose) and trimethylamine
N-oxide (78% dose) [109], but failed to show ingestion of betaine, creatinine or lecithin elicited
significant increases. However, in rats, creatinine feeding slightly increased urinary TMA levels [110].
TMANO elevation does not necessarily depend on gut microbiota upon consumption of dietary
precursors like choline. Moreover, TMANO is eliminated rapidly in healthy adults but sustained
elevation is seen in atherosclerotic patients and elevated TMANO levels are found in animal models
of disease [111]. Further, TMANO is not always associated with disease or any adverse effect,
and potential therapeutic applications of TMANO include protective functions in numerous organisms
like bacteria where it also maintains cell volume, protecting cells from osmotic and hydrostatic damage
(see concluding remarks for more putative beneficial findings).
In a study investigating TMANO formation from 46 different ingested foods, only fish and other
sea-foods gave rise to significant increases in urinary trimethylamine and N-oxide [109], whereas fruits,
vegetables, cereal, dairy and meats had no measurable effects on TMANO levels since they lack TMA in
the first place. Serum TMANO levels are affected by not only diet and gut microbial distribution but by
antibiotic administration and liver flavin monooxygenase (FMO3) activity among others. In that regard,
human FMO3, which oxidizes nucleophilic heteroatom-containing xenobiotics, will also oxidize TMA
in the liver to TMANO [109,112] Again, and important for this discussion, TMANO/TMAO is important
to track the redox reaction mechanisms since TMANO itself can be reduced in the gastrointestinal
tract to trimethylamine and dimethylamine [105,113]. In that regard, it was demonstrated that oral
dosing of TMANO 78% was recovered unmodified in the urine and about half the dose was reduced to
TMA in the gut, which was then re-oxidized in the liver to TMANO before excretion. So, up to half of
the TMANO consumed is excreted unchanged [114].
Other foods have significantly more choline than eggs and a more significant impact on TMANO
production. Nevertheless, this study appears to implicate meat consumption for the increased
production. It appears that excessive intake of red meat in particular and foods high in choline
readily increase plasma TMANO levels, which can cause blood clots and increases the risk of heart
disease [115]. For example, a study on dietary effects of 46 different foods on urinary excretion of
TMANO in 6 human volunteers showed eggs had largely no effect on TMANO excretion, but many
sea foods did as seafood contains TMA and the TMANO is derived from TMA via direct oxidation
of the amino group. In addition, fish contain lower amounts of choline than eggs, which may argue
for the direct oxidation and stochastic conversion mechanism of TMA to TMANO over enzymatic
metabolism or at least offer an additional pathway.
One approach to preventing heart disease from this research group was to inhibit host enzymes
that convert TMA to TMANO, but this caused the formation of pro-atherogenic intermediates [115]
and the approach presumably caused liver damage and accumulation of toxic TMA. The better approach
may be to target specific gut microbes to prevent TMA formation in the first place. Ongoing efforts to
inhibit TMANO production without understanding why in this study vegetarians have lower amounts
of TMANO and choline, and even took choline supplements, than those who ate meat confounds
any proposed hypotheses and question the use inhibitors at this point. Although there are cultural
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differences, dietary preferences, and prebiotics which could offer explanations for some of these effects,
there are still genetic and epistatic and environmental unknowns to be elucidated. For example, it
is intriguing that Indian, French and Mediterranean people, whom all eat high-choline and high
betaine-containing foods, or are largely vegetarian, have relatively good heart health in spite of likely
having the same intestinal bacterial microbiota.
When choline is supplemented orally over two months, production of trimethylamine N-oxide
increased ten-fold [105] The CCF researchers found that the compounds present in animal products
increase the levels of TMANO, which may directly cause platelets to form blood clots. This finding
helped link chronic diseases, such as obesity, atherosclerosis and diabetes with the gut microbiota.
What it does seem to indicate is a strong microbial involvement in pathogenesis and CHD risk.
However, these findings and newer ones on microbial enzyme transformation add considerable
confusion to the story of the French paradox as PC, choline and betaine are compounds that share
routes of metabolism and production. While this study involved both a broad spectrum antibiotic
and animal studies using germ-free mice and suggests heart disease has a bacteria-derived biochemical
component to its pathogenesis, it leaves many questions unanswered. TMANO may have a role in
protecting the brain and certainly the case has been made for PC and choline in brain health.
However, flavonoids and lignans form wine have both antiplatelet and antithrombogenic activity,
which is mediated through binding of cyclooxygenase [116]. Their anti-thrombogenic activity
and anti-inflammatory properties are mediate through inhibition of the metabolism of arachidonic
acid [116], which is an important inflammatory precipitating molecule by neutrophils that use
lipoxygenase and arachidonic acid for chemotaxis. Nevertheless, these initial studies lack full
exploration of not only the consortium of bacteria involved, but they create more questions than
answers about consuming eggs and meat vs. vegetarianism and beg for much more basic science.
Given the confusion around choline, betaine and since Dietary Reference Intakes (DRIs) are largely
determined through human observational and depletion-repletion studies. However, it is difficult
to ascertain a dietary recommended daily allowance (RDA) for choline intake, which although was
established, adequate intake is expected to be 425 milligrams per day for women and 550 milligrams
a day for men. [117]. Nevertheless, if choline-containing foods really are key to TMANO production
in vivo, and if high TMANO causes heart disease, then one would expect greater rates of CHD among
people who eat more fish, whole grains and choline rich foods, since these are a fair component of
a Mediterranean diet and these foods produce more TMANO. Yet, this is the opposite of what cohort
studies indicate, as eating more fish especially wild caught cold-water, fatty fish like salmon, rich in
omega 3 fatty acids has consistently been shown in randomized controlled trials to reduce the risk
of death from coronary heart disease, mortality and sudden death [118]. Recently, blood levels of
long-chain omeg-3 fatty acids were found to be strongly associated with a reduced risk of sudden
death among men without prior cardiovascular disease [119] and heart rate is positively associated
with risk of sudden death in men [120].
11. TMANO-mediated Damage or Health Benefits
TMANO is suspected of being many things from pharmacological therapeutic agent to
evolutionary remnant of an osmolytes-regulation system among others. Among others, mutant
protein chaperone [121] and helpful against diverse ocular diseases, such as cataracts [122], glaucoma,
corneal dystrophies and other ocular diseases [123]. Moreover, several mechanisms affect TMANO
homeostasis in vivo and plasma levels are dependent upon numerous factors including, diet, microbial
composition of the gut and medications other than antibiotics. However, anything that controls the rate
of TMA formation or its excretion, like the permeability to TMA and TMANO of the blood intestinal
barrier or the excretion of the methylamines [113,124] will also affect TMANO levels. Further, kidneys
maintain TMANO homeostasis by regulating water-electrolyte balance and excretion rates are also
regulated by functioning healthy kidneys.
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In regard to kidney function and renal insufficiency, TMANO’s effect on increased atherosclerosis
and heart disease risk in humans and rats may involve its interaction with angiotensin II [125] which,
interestingly, affects cholesterol metabolism [126]. Moreover, related to kidney function, angiotensin
converting enzyme inhibitors (ACE-I) are used to treat cardiovascular, kidney and heart diseases
and are known to reduce cardiovascular mortality [127]. When the ACE-I Enalapril was used in patients
and rodent models, it reduced plasma TMANO level, but it is known to also affect composition of gut
bacteria and the plasma level of several gut bacteria-derived metabolites including the generic bacterial
maker indoxyl (or indican) [123] The mechanism for the enalapril reduction of plasma TMANO is not
well characterized and an increased urinary excretion of TMANO or methylamines can’t be ruled out.
However, over time enalapril may disrupt kidney function, disrupt electrolyte levels [128] and lead
to kidney failure. When the same group studied enalapril-treated rats, no markers of kidney failure
were found [129] with the bacterial marker indican (Indoxyl sulfate) were observed. It is important to
note that Enalapril is a diuretic and natriuretic and rats given this drug had higher water intake that
controls [130] and effect of ACE-I on the gut–blood barrier permeability and methylamine homeostasis
is not known [123] but this affect could have benefit in cardiovascular disease that involve urinary
excretion of deleterious metabolite.
12. TMANO and Leaky Gut
In regard to leaky gut, leaky brain and other barrier permeability states, it is suggested that
TMANO might cause BBB or other barrier disruption by reducing the expression of tight junction
protein-1 ZO-1 and claudin-5 [131]. Moreover, leaky gut is a serious consideration for the transmission
of bacteria and material components or Lipopolysaccharide (LPS) into the systemic circulation. Further,
leaky gut and gluten sensitivities have been considered to cause or contribute to inflammatory
states especially with the autoimmune disease Celiac, which is characterized by inflammation of
the intestinal mucosa in the small intestine due to an immune response and the loss of tolerance
to dietary gluten. Moreover food sensitivity and emerging food glycotoxins that have been linked
to systemic inflammation, especially in regard to celiac disease (CD), depression and psychiatric
comorbidities [3].
Inflammation in the body may lead to direct and even disruptive effects on the brain via
the blood–brain barrier and blood-gut barrier. This may be perhaps why we find TMANO in the brain.
During systemic inflammation, whether from infection or LPS translocation, the BBB may undergo
changes in patients with neurological disease to become abnormally sensitive to the effects of systemic
inflammation [6]. Conversely, several lines of evidence suggest that TMANO may play a protective role
in cardiovascular system by reducing deleterious effects of oxidative stress. For example, it has been
found that oral supplementation of L-carnitine increases plasma TMA and TMANO levels and decreases
markers of oxidative stress and vascular injury, such as vascular cell adhesion molecule-1, soluble forms
of intracellular adhesion molecule-1 (ICAM 1), and malondialdehyde [132]. Furthermore, treatment
with TMANO has been found to inhibit the negative effects of oxidative stress in streptozotocin
diabetic rats [133] and human neuroblastoma cells [134]. However, the mechanisms are not clear.
TMANO has also been found to act as an electron acceptor in bacteria [135]. Therefore, it may neutralize
electrons that leaked from the mitochondrial electron transport chain reducing the formation of reactive
oxygen species.
13. Pathogenic Bacteria and Disease
In addition to heart disease, Alzheimer disease, schizophrenia, ASD and autism are increasingly
expected to be influenced by the gut microbiota. In that regard, it is well established that bacteria can
directly cause human blood and plasma to clot. Moreover, these coagulation states can be acquired
from systemic diseases or sequalae associated with an increased risk of thrombosis. For instance,
hyperlipidemia, malignancy, myeloproliferative disorders, use of oral contraceptives, pregnancy,
and even diabetes all are known to cause hyper-coagulation [136]. Previous conventional thought
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suggested this process was lost during vertebrate evolution. One key to clot formation is the location
of the bacteria or infection site but coagulation only occurs when bacteria cluster into a foci of
critical mass [137]. Since we know choline does feed select gut bacteria and it is known certain
bacteria can produce clot-forming compounds and contribute to a hyper-coagulability or secondary
hypercoagulable states in humans, perhaps focusing on the bacteria, fungi and parasites would
render a fuller understanding of these diseases and advance medicine in ways never before imagined.
While this is important for possibly increasing stroke or heart attack risk, it begs the question as to
whether or not innocuous and even beneficial foods can be antagonistically pleiotropic with respect to
the action of select gut bacteria.
It is important to revisit redox mechanisms in regard to TMANO as it potentially affects
oxidation-reduction mechanisms, impair fatty acid oxidation in cardiac mitochondria [138] and serve
as an electron acceptor in animal intestines for anaerobic metabolism of various bacteria like
Enterobacteriaceae [135]. These researchers found TMANO to support oxidative phosphorylation
in Enterobacteriaceae, which is a common bacteria in mammals. In the Colon, anaerobic respiration with
TMANO was at the same time able to inhibit the facultative pathogen Staphylococcus aureus and other
bacterial growth [139]. Facultative anaerobes, such as bacteria belonging to the groups Bacillus,
Staphylococcus, Corynebacterium, Fusobacterium and many members of the phylum Proteobacteria are
opportunistic species, especially Enterobacteriaceae, thrive in an inflamed environment [140]. Substantial
evidence exists that TMANO may play an important role in the global carbon and nitrogen cycles [141]
and we should mention that oral infections and bacteria play a role in heart disease.
Further, carnitine, abundant in meat and high energy drinks may responsible for increasing
production of smaller amounts of TMANO from bacterial metabolism. What we don’t know is
which specific bacteria, are involved, although Prevotella bacteria is known to produce higher levels
of TMANO. Intestinal microbiota metabolism of L-carnitine, which promote atherosclerosis [126],
is found from whole grain and not animal product consumption that is associated with higher levels
of Prevotella bacteria [142]. The author speculates that meat and carnitine-loving bacteria are key
players. Alternatively, Clostridia difficlie may be another culprit and find that Clostridia difficlie is lower
in vegetarians vs. carnivores (unpublished observations). Yet, carnitine supplementation coupled with
alpha lipoic acid, is able to protect the heart and brain from oxidative stress, aging and possibly bacterial
action and may be one solution to the problem. Moreover, polyphenols help prevent inflammation
and oxidation and thus help prevent downstream effects from these processes, which are implicated in
almost every disease [7].
So, while it cannot be concluded that choline, betaine and carnitine are responsible for strokes or
heart disease, we should not eliminate them from the diet. The Cleveland Clinic Foundation researchers
demonstrated that a Mediterranean diet altered the activity of gut microbes, which may be the very
node that modifies bacterial risk in humans. Nevertheless, scientists should explore bacteria-host
co-metabolism with phenolic acids, antioxidants and polyphenol administration and sequence
the microbiota of the heart healthy for genetic associations or polymorphisms to gain a better
understanding. Regardless, it may be best to consume TMANO-promoting foods in moderation,
or focus on eating more vegetation or drink a glass of red wine per day and so on or at least until all
the facts are made clear. Other foods in the aforementioned dietary challenge like fish, whole grain etc.
may increase Prevotella colonization [143].
Polyphenols help lower systemic inflammation, improve metabolic syndrome and favorably
affect the microbiota as a prebiotic. They also induce the microbiota to release prebiotics, such as
SCFAs [144]. In addition to using prebiotics to modulate the microbiota, a useful approach to inhibit or
counter damaging metabolic products from harmful bacteria may be to use beneficial probiotics to
change the kinetics of the harmful bacterial species or compete for substrates. For instance, there are
many rare and valuable enzymes useful for chemical synthesis. However, physiologic constraints like
instability, unfavorable thermodynamics or poor kinetics do severely limit their usefulness in particular
applications. Harnessing the microbiota in fermenters, or other synthetic approaches, to synthesize
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medicinal compounds or natural products as drugs or antibiotics could help deliver these new
treatments quickly and on a large scale. For example, a research group from Tufts recently employed
a microbial approach to surpassing isomerization catalysis barriers for D-Tagatose biosynthesis [145].
The value of this rare ketohexose sugar as a commodity for its safety, per United States Department of
Agriculture, which is (generally regarded as safe or given GRAS designation) as a substitute for diabetic
use and it has a low glycemic index, similar sweetness to sucrose and a low calorie content [145].
The same authors created an enzymatic reaction system using Lactobacillus sakei and Lactobacillus
arabinose isomerase to isomerize of D-galactose to D-tagatose. They overcame low catalytic efficiency
and low thermal stability by encapsulating the enzyme in a gram-positive Lactobacillus plantarum,
which was chemically permeable and enabled high reaction rates at high temperatures [145]. What this
approach serves to illustrate is proof of concept that the application of microbiology to inhibit bacterial
production of deleterious substrates like Trimethylamine or downstream products like TMANO.
14. Conclusions
Since polyphenols and antioxidants are able to counteract many deleterious bacteria-driven
mechanisms, it follows that unwanted co-metabolism could be inhibited by prosaic foods rather
than with inhibitors or drugs. Natural compounds are preferred over synthetic ones since they are
readily available, inexpensive, and comparatively less toxic. However, they are very difficult to
synthesize commercially. Nevertheless, support for this notion comes from the Cleveland Clinic
Foundation researchers, themselves, who found that prosaic foods like cold-pressed extra virgin olive
oil, balsamic vinegar and grape seed oils could also inhibit microbes from transforming meat, choline,
betaine and carnitine into metabolic by-products of TMANO in animal studies, but they did not explore
antioxidants or redox mechanisms directly.
There is considerable conjecture about vitamin supplementation and choline is not exempt.
High levels of TMANO are associated with a greater risk of heart attack and stroke. However,
according to a large Finnish study, adequate intake of choline reduced the risk of dementia [146],
cardiovascular disease and cancer. The data for the study were derived from the Kuopio Ischemic
Heart Disease Risk Factor Study, which analyzed approximately 2500 men aged between 42 and 60
for their dietary general health and lifestyle habits. They observed that dietary phosphatidylcholine
intake (largely from eggs and meat) was associated with reduced dementia risk. Phosphatidylcholine
intake was also associated with enhanced cognitive performance. This is not surprising, given that
choline is necessary for the formation of acetylcholine a key neurotransmitter. If one goes further to
consider the microbiota-gut-brain axis as both culprit and cure to not only prevent atherosclerosis,
but prevent brain and other disorders as well and do it through microbiota-host co-metabolism [147].
Key to this hypothesis is both diet and targeting select gut bacteria to either prevent or treat disease.
In other words, using “Bugs as Drugs” or using antimicrobial substances like polyphenols to modulate
health and disease. So, while possible to prevent the diet-induced heart disease that starts from the gut,
researchers still don’t understand all this would entail. But it is clear that funding basic science is still
a valuable investment and there should be so much more of it.
Technical aspects typical with human studies like the TMANO studies make our determination
difficult such as those from confounding factors like diet and the constitution of the study subjects.
For example, kidney function is important in toxin clearance and we see filtration rate and kidney
function from some study participants but any impaired urinary clearance of TMANO or impaired
kidney function would diminish the results. The conjecture is supported in the New England Journal
of Medicine paper, where the highest levels of TMANO had an average glomerular filtration rate (GFR)
of 69 mL/min, which is indicative of a reduced filtration determined as a GFR between 60–89 mL/min.
In their defense, however, a healthy volunteer study was conducted where the results appeared to hold.
Further, the microbial milieu should be determined throughout these studies as some gut microbiota,
i.e., Prevotella species are known to predispose one to increases in TMANO production [148].
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In summation, we cannot say that choline and betaine are protective or deleterious as food
consumption goes, but they do affect many aspects of our health, especially when considering potential
transformation by enteric bacteria in the colon. Nevertheless, consuming excess choline-rich foods
or when supplements are added, may increase TMANO levels and could increase the risk of heart
disease. Yet, the betaine, when consumed in red wine, however, may be protective and red wine
with a choline-rich meal may impart similar protection from choline formation via a microbial route.
As yet, no one has established a clear mechanism for how the French enjoy their food or any heart
disease-sparing mechanism and more work is necessary to address these aspects, which we elucidate
here both for the microbiota gut brain heart shunt and in neurodegenerative disease. This work calls
for reexamining many experimental approaches and couple them with exploring the microbiota of
the French. Taken together, we argue that oxidative stress, through microbial action and metabolism,
could contribute to TMANO formation but other factors may be more important in modulating heart
and cerebrovascular disease and related forms of AD, VaD and dementia (See Figure 4 for an overview).
While the figure is somewhat complicated, it is clear that the answers to the questions surrounding
the French paradox are complicated as well. A quote paraphrased from “Sleeper” (1973, United Artists),
a futuristic Woody Allen comedy, in which this character Miles says ”I used to run a health food store,
The Happy Carrot in the West Village one day I went in for routine surgery only to wake up two
hundred years later to find everything that I was told was good for me is bad for me and everything that
was bad for me is good for me.” It often seems like this when exploring the paradoxical, which means
things do not always make sense and can be contrary to the expected. Nevertheless, we have much
more to learn about this important topic and the roles the microbiota gut brain axis play in heart health,
heart disease and neurodegenerative diseases.
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optimally produce beneficial SCFAs, neurotransmitters and hormones. The bidirectional pathway
for toxin and psychoactive substance production affect both the brain and the heart. Conversely,
gut derived hormones, peptides, small molecules and neurotransmitters have a useful role in health
and in both prevention of heart and brain diseases.
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and special mention to Engine Industries and B.M. who prepared figures to publication standards. All authors
have read and agreed to the published version of the manuscript.
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